×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
Session 3 : How to Leverage Innovative Tools to Accelerate Drug development for Asian Patients
Session Chair(s)
Hyouyoung Rhim, MD, MSc
Vice President
Yuhan Pharm inc., Korea, Republic of
Jing Ping Yeo, PhD
Global Head, Project Operations & Head, Transformation
George Clinical, Singapore
Speaker(s)
Meghana Chalasani, MHA
FDA, United States
Associate Director for Clinical Trial Innovation, Office of New Drugs, CDER
Session 3 - 2
Sergey Denisov
Seltasquare, Korea, Republic of
Sr. ML Engineer
Session 3 - 3
Henry Wu
AstraZeneca R&D China, China
Sr. Director, Regional Lead-China, HK and Eurasia
Session 3 - 4
Atsushi Ogawa
ICON Japan K.K., Japan
Fengyun (Vicky) Han
Johnson & Johnson Pte. Ltd., Singapore
Senior Director, Head of Regulatory Policy for Asia Pacific
Jing Ping Yeo, PhD
George Clinical, Singapore
Global Head, Project Operations & Head, Transformation